ROSSO, Chiara
ROSSO, Chiara
SCIENZE MEDICHE
A new index of glutathione turnover (GSH_TI) and its association with severity of non-alcoholic fatty liver disease (NAFLD).
2014-01-01 Gaggini, M.; Saponaro, C.; Vanni, Ester; Rosso, Chiara; Carli, F.; Buzzigoli, E.; Abate, Maria Lorena; Ciociaro, D.; Mezzabotta, Lavinia; Gambino, Roberto; Cassader, Maurizio; Bugianesi, Elisabetta; Gastaldelli, A.
A NOVEL APPROACH FOR HEPATITIS DELTA VIRUS VIREMIA QUANTIFICATION BY DROPLET DIGITAL PCR ASSAY
2016-01-01 Olivero, A.; Abate, M.L.; Niro, G.; Caviglia, G.P.; Rosso, C.; Ciancio, A.; Fontana, R.; Smedile, A.; Rizzetto, M.; Saracco, G.M.
Absolute quantification of intrahepatic HBV covalently-closed-circular DNA by droplet digital PCR
2017-01-01 Gian Paolo Caviglia; Maria Lorena Abate; Antonella Olivero; Chiara Rosso; Alessia Ciancio; Elisabetta Bugianesi; Giorgio Maria Saracco; Antonina Smedile
Absolute quantification of intrahepatic hepatitis B virus covalently-closed-circular DNA by droplet digital PCR technology
2017-01-01 Caviglia, G.P.; Abate, M.L.; Olivero, A.; Rosso, C.; Ciancio, A.; Bugianesi, E.; Saracco, G.M.; Smedile, A.
Adipose tissue insulin resistance and inflammation, but not reduced hepatic fat oxidation, are associated to active NASH and severe fibrosis.
2020-01-01 Amalia Gastaldelli, Melania Gaggini, Michael Allison, Ramy Younes, Chiara Rosso, Jorn M. Schattenberg, Vlad Ratziu, Elisabetta Bugianesi, Quentin Anstee
Adipose tissue insulin resistance is associated with macrophage activation in non-diabetic patients with non-alcoholic fatty liver disease
2016-01-01 Marietti, M.; Rosso, C.; Gaggini, M.; Saponaro, C.; Kazankov, K.; Buzzigoli, E.; Holler, H.J.; Caviglia, G.P.; Abate, M.L.; Smedile, A.; Saracco, G.M.; Vilstrup, H.; George, J.; Gronbaek, H.; Gastaldelli, A.; Bugianesi, E.
Adverse impact of visceral fat on lipid and metabolic profile in fatty liver disease
2015-01-01 Saponaro, C; Gaggini, M; Rosso, C; Buzzigoli, E; Carli, F; Ciociaro, D; Mezzabotta, L; Vanni, E; Saba, F; Abate, M; Smedile, A; Rizzetto, M; Bugianesi, E; Gastaldelli, A
After oral fat load NAFLD subjects and healthy controls show different serum free fatty acid trends.
2014-01-01 R. Gambino; E. Bugianesi; C. Rosso; L. Mezzabotta; S. Pinach; N. Alemanno; F. Saba; M. Cassader
Alteration in glucose metabolism after an oral glucose load and relationship with liver damage in patients with NAFLD.
2014-01-01 E. Vanni; L. Mezzabotta; C. Rosso; M. Gaggini; R. Gambino; F. Salomone; E. Buzzigoli; C. Saponaro; F. Saba; D. Ciociaro; G.P. Caviglia; M.L. Abate; S. Carenzi; A. Smedile; M. Rizzetto; M. Cassader; A. Gastaldelli; E. Bugianesi.
Alteration in glucose metabolism after an oral glucose load in patients with non-alcoholic fatty liver disease.
2014-01-01 E. Vanni; L. Mezzabotta; C. Rosso; M. Gaggini; R. Gambino; F. Salomone; E. Buzzigoli; C. Saponaro; F. Saba; D. Ciociaro; G.P. Caviglia; M.L. Abate; S. Carenzi; A. Smedile; M. Rizzetto; M. Cassader; A. Gastaldelli; E. Bugianesi.
Alteration in lipid metabolism after an oral fat load in non-alcoholic fatty liver disease.
2014-01-01 L. Mezzabotta; E. Vanni; C. Rosso; M. Gaggini; R. Gambino; E. Buzzigoli; C. Saponaro; D. Ciociaro; M.L. Abate; F. Saba; F. Salomone; G.P. Caviglia; S. Carenzi; A. Smedile; M. Rizzetto; M. Cassader; A. Gastaldelli; E. Bugianesi.
Alteration in lipid metabolism after an oral fat load in patients with NAFLD.
2014-01-01 L. Mezzabotta; E. Vanni; C. Rosso; M. Gaggini; R. Gambino; E. Buzzigoli; C. Saponaro; D. Ciociaro; M.L. Abate; F. Saba; F. Salomone; G.P. Caviglia; S. Carenzi; A. Smedile; M. Rizzetto; M. Cassader; A. Gastaldelli; E. Bugianesi
Alteration in lipid metabolism after an oral fat load in subjects with NAFLD.
2013-01-01 Gastaldelli A.; Gaggini M.; Mezzabotta L.; Rosso C.; Carli F.; Ciociaro D.; Gambino R.; Carenzi S.; Saba F.; Cassader M.; Bugianesi E
Angiopoietin like protein 4 (ANGPTL4): a marker of alteration in lipid metabolism, insulin resistance and ectopic fat accumulation
2016-01-01 Gastaldelli, A.; Gaggini, M.; Rosso, C.; Della Latta, V.; Marietti, M.; Caviglia, G.; Carli, F.; Buzzigoli, E.; Ciociaro, D.; Abate, M.; Smedile, A.; Saracco, G.; Bugianesi, E.
Angiopoietin-like4 is associated with lipid metabolism and severe fibrosis in non-diabetic patients with non-alcoholic fatty liver disease
2016-01-01 Rosso, C.; Gaggini, M.; Saponaro, C.; Marietti, M.; Caviglia, G.P.; Carli, F.; Buzzigoli, E.; Abate, M.L.; Smedile, A.; Saracco, G.M.; Gastaldelli, A.; Bugianesi, E.
Application of serum cytokeratin-19 fragments (CYFRA 21-1) in predicting the prognosis of patients with hepatocellular carcinoma
2020-01-01 Gian Paolo Caviglia, Antonella Olivero, Michela Ciruolo, Patrizia Carucci, Emanuela Rolle, Chiara Rosso, Maria Lorena Abate, Alessandra Risso, Ramy Younes, Antonina Smedile, Giorgio Maria Saracco, Elisabetta Bugianesi, Silvia Gaia
Bile acids composition modulate insulin resistance in non-diabetic patients with NAFLD
2018-01-01 C. Rosso, R. Younes, M. Eslam, FW. Chen, M. Cucco, M. Gaggini, S. Coulter, F. Carli, C. Barbieri, V. della Latta, M.L. Abate, GM. Saracco, A. Gastaldelli, J. George, E. Bugianesi
Characterization of a novel chemiluminescent enzyme immunoassay for the quantitation of antibodies to hepatitis B core antigen class IgG and correlation with intrahepatic HBV covalently-closed-circular DNA
2019-01-01 Gian Paolo Caviglia, Francesco Tandoi, Giulia Troshina, Lucio Boglione, Chiara Rosso, Elisabetta Bugianesi, Alessia Ciancio, Renato Romagnoli, Mario Rizzetto, Giorgio Maria Saracco, Antonina Smedile, Antonella Olivero
Clinical Characteristics and Long-Term Outcomes of Lean Caucasian Patients with Non- Alcoholic Fatty Liver Disease. a Longitudinal International Study.
2018-01-01 Ramy Younes, Olivier Govaere, Salvatore Petta, Luca Miele, Anna Ludovica Fracanzani, Chiara Rosso, Antonio Liguori, Paolo Francione, Mohammed Eslam, Luca Valenti, Jacob George, Quentin M. Anstee, Elisabetta Bugianesi
Contribution of visceral fat and hepatic fat to metabolic derangements and liver damage in NAFLD patients.
2013-01-01 L. Mezzabotta; E. Vanni; C. Rosso; S. Carenzi; R. Gambino; M. Gaggini; D. Lucarelli; R. Faletti; M. Cassader; A. Smedile; M. Rizzetto; A. Gastaldelli; E. Bugianesi
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
A new index of glutathione turnover (GSH_TI) and its association with severity of non-alcoholic fatty liver disease (NAFLD). | 2014 | Gaggini, M.; Saponaro, C.; Vanni, Ester; Rosso, Chiara; Carli, F.; Buzzigoli, E.; Abate, Maria Lorena; Ciociaro, D.; Mezzabotta, Lavinia; Gambino, Roberto; Cassader, Maurizio; Bugianesi, Elisabetta; Gastaldelli, A. | |
A NOVEL APPROACH FOR HEPATITIS DELTA VIRUS VIREMIA QUANTIFICATION BY DROPLET DIGITAL PCR ASSAY | 2016 | Olivero, A.; Abate, M.L.; Niro, G.; Caviglia, G.P.; Rosso, C.; Ciancio, A.; Fontana, R.; Smedile, A.; Rizzetto, M.; Saracco, G.M. | |
Absolute quantification of intrahepatic HBV covalently-closed-circular DNA by droplet digital PCR | 2017 | Gian Paolo Caviglia; Maria Lorena Abate; Antonella Olivero; Chiara Rosso; Alessia Ciancio; Elisabetta Bugianesi; Giorgio Maria Saracco; Antonina Smedile | |
Absolute quantification of intrahepatic hepatitis B virus covalently-closed-circular DNA by droplet digital PCR technology | 2017 | Caviglia, G.P.; Abate, M.L.; Olivero, A.; Rosso, C.; Ciancio, A.; Bugianesi, E.; Saracco, G.M.; Smedile, A. | |
Adipose tissue insulin resistance and inflammation, but not reduced hepatic fat oxidation, are associated to active NASH and severe fibrosis. | 2020 | Amalia Gastaldelli, Melania Gaggini, Michael Allison, Ramy Younes, Chiara Rosso, Jorn M. Schattenberg, Vlad Ratziu, Elisabetta Bugianesi, Quentin Anstee | |
Adipose tissue insulin resistance is associated with macrophage activation in non-diabetic patients with non-alcoholic fatty liver disease | 2016 | Marietti, M.; Rosso, C.; Gaggini, M.; Saponaro, C.; Kazankov, K.; Buzzigoli, E.; Holler, H.J.; Caviglia, G.P.; Abate, M.L.; Smedile, A.; Saracco, G.M.; Vilstrup, H.; George, J.; Gronbaek, H.; Gastaldelli, A.; Bugianesi, E. | |
Adverse impact of visceral fat on lipid and metabolic profile in fatty liver disease | 2015 | Saponaro, C; Gaggini, M; Rosso, C; Buzzigoli, E; Carli, F; Ciociaro, D; Mezzabotta, L; Vanni, E; Saba, F; Abate, M; Smedile, A; Rizzetto, M; Bugianesi, E; Gastaldelli, A | |
After oral fat load NAFLD subjects and healthy controls show different serum free fatty acid trends. | 2014 | R. Gambino; E. Bugianesi; C. Rosso; L. Mezzabotta; S. Pinach; N. Alemanno; F. Saba; M. Cassader | |
Alteration in glucose metabolism after an oral glucose load and relationship with liver damage in patients with NAFLD. | 2014 | E. Vanni; L. Mezzabotta; C. Rosso; M. Gaggini; R. Gambino; F. Salomone; E. Buzzigoli; C. Saponaro; F. Saba; D. Ciociaro; G.P. Caviglia; M.L. Abate; S. Carenzi; A. Smedile; M. Rizzetto; M. Cassader; A. Gastaldelli; E. Bugianesi. | |
Alteration in glucose metabolism after an oral glucose load in patients with non-alcoholic fatty liver disease. | 2014 | E. Vanni; L. Mezzabotta; C. Rosso; M. Gaggini; R. Gambino; F. Salomone; E. Buzzigoli; C. Saponaro; F. Saba; D. Ciociaro; G.P. Caviglia; M.L. Abate; S. Carenzi; A. Smedile; M. Rizzetto; M. Cassader; A. Gastaldelli; E. Bugianesi. | |
Alteration in lipid metabolism after an oral fat load in non-alcoholic fatty liver disease. | 2014 | L. Mezzabotta; E. Vanni; C. Rosso; M. Gaggini; R. Gambino; E. Buzzigoli; C. Saponaro; D. Ciociaro; M.L. Abate; F. Saba; F. Salomone; G.P. Caviglia; S. Carenzi; A. Smedile; M. Rizzetto; M. Cassader; A. Gastaldelli; E. Bugianesi. | |
Alteration in lipid metabolism after an oral fat load in patients with NAFLD. | 2014 | L. Mezzabotta; E. Vanni; C. Rosso; M. Gaggini; R. Gambino; E. Buzzigoli; C. Saponaro; D. Ciociaro; M.L. Abate; F. Saba; F. Salomone; G.P. Caviglia; S. Carenzi; A. Smedile; M. Rizzetto; M. Cassader; A. Gastaldelli; E. Bugianesi | |
Alteration in lipid metabolism after an oral fat load in subjects with NAFLD. | 2013 | Gastaldelli A.; Gaggini M.; Mezzabotta L.; Rosso C.; Carli F.; Ciociaro D.; Gambino R.; Carenzi S.; Saba F.; Cassader M.; Bugianesi E | |
Angiopoietin like protein 4 (ANGPTL4): a marker of alteration in lipid metabolism, insulin resistance and ectopic fat accumulation | 2016 | Gastaldelli, A.; Gaggini, M.; Rosso, C.; Della Latta, V.; Marietti, M.; Caviglia, G.; Carli, F.; Buzzigoli, E.; Ciociaro, D.; Abate, M.; Smedile, A.; Saracco, G.; Bugianesi, E. | |
Angiopoietin-like4 is associated with lipid metabolism and severe fibrosis in non-diabetic patients with non-alcoholic fatty liver disease | 2016 | Rosso, C.; Gaggini, M.; Saponaro, C.; Marietti, M.; Caviglia, G.P.; Carli, F.; Buzzigoli, E.; Abate, M.L.; Smedile, A.; Saracco, G.M.; Gastaldelli, A.; Bugianesi, E. | |
Application of serum cytokeratin-19 fragments (CYFRA 21-1) in predicting the prognosis of patients with hepatocellular carcinoma | 2020 | Gian Paolo Caviglia, Antonella Olivero, Michela Ciruolo, Patrizia Carucci, Emanuela Rolle, Chiara Rosso, Maria Lorena Abate, Alessandra Risso, Ramy Younes, Antonina Smedile, Giorgio Maria Saracco, Elisabetta Bugianesi, Silvia Gaia | |
Bile acids composition modulate insulin resistance in non-diabetic patients with NAFLD | 2018 | C. Rosso, R. Younes, M. Eslam, FW. Chen, M. Cucco, M. Gaggini, S. Coulter, F. Carli, C. Barbieri, V. della Latta, M.L. Abate, GM. Saracco, A. Gastaldelli, J. George, E. Bugianesi | |
Characterization of a novel chemiluminescent enzyme immunoassay for the quantitation of antibodies to hepatitis B core antigen class IgG and correlation with intrahepatic HBV covalently-closed-circular DNA | 2019 | Gian Paolo Caviglia, Francesco Tandoi, Giulia Troshina, Lucio Boglione, Chiara Rosso, Elisabetta Bugianesi, Alessia Ciancio, Renato Romagnoli, Mario Rizzetto, Giorgio Maria Saracco, Antonina Smedile, Antonella Olivero | |
Clinical Characteristics and Long-Term Outcomes of Lean Caucasian Patients with Non- Alcoholic Fatty Liver Disease. a Longitudinal International Study. | 2018 | Ramy Younes, Olivier Govaere, Salvatore Petta, Luca Miele, Anna Ludovica Fracanzani, Chiara Rosso, Antonio Liguori, Paolo Francione, Mohammed Eslam, Luca Valenti, Jacob George, Quentin M. Anstee, Elisabetta Bugianesi | |
Contribution of visceral fat and hepatic fat to metabolic derangements and liver damage in NAFLD patients. | 2013 | L. Mezzabotta; E. Vanni; C. Rosso; S. Carenzi; R. Gambino; M. Gaggini; D. Lucarelli; R. Faletti; M. Cassader; A. Smedile; M. Rizzetto; A. Gastaldelli; E. Bugianesi |